Skip to main content

Login

Subscribe

Main navigation

Show — Main navigation Hide — Main navigation

Home
Features
Conferences
- CIO Meeting
- Events
CME
Multimedia
- Podcasts
- Videos
About

Listing Page

Stay in the know

IO Learning Newsletter

News

SonALAsense Pioneers Sonodynamic Therapy, a First-in-Class Noninvasive Therapy for Lethal Brain Cancers; Enters Into a Collaboration and License Agreement With Insightec and a Collaboration Agreement with Ivy Brain Tumor Center to Conduct the First-in-Man

New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment

ESMO ASIA Congress 2020 | CStone Pharmaceuticals announces the results of GEMSTONE-302, Sugemalimab has the potential to provide a new treatment option for patients with advanced NSCLC

Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020

The University of Verona and IntraOp® Announce PancFORT Trial for Pancreatic Cancer

Back to Top

Connect

Facebook
Twitter
LinkedIn

ABOUT

About Us
Contact Us
Privacy Policy

VISIT OUR OTHER BRANDS

Amputation Prevention Symposium (AMP)
AMP Europe
Cath Lab Digest
Cath Lab Live
EP Lab Digest
International Symposium on Endovascular Therapy (ISET)
Journal of Invasive Cardiology
Leipzig Interventional Course (LINC)
Symposium on Clinical Interventional Oncology (CIO)
Vascular Disease Management

© 2021 HMP. IOLearning is a trademark of HMP. All Rights Reserved.